HIV-associated Lipodystrophy Market Size, Share, Industry, Forecast and Outlook (2023-2030)
Published: 2023 December 26
SKU : PH6768
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
FAQ’s
Who are the key players in the HIV-associated Lipodystrophy Market ?
Major players are Theratechnologies Inc., Amryt Pharmaceuticals, Inc., Fawn Incorporation, Abbott Healthcare Solutions, Lupin Pharmaceuticals, Inc., Pfizer Inc., Bayer Inc., AstraZeneca, Novartis Pharmaceuticals Corporation, AbbVie, Galderma Laboratories, L.P. and GlaxoSmithKline.
How big is the HIV-associated Lipodystrophy Market ?
Global HIV-associated Lipodystrophy Market reached US$ 174.90 million in 2022 and is expected to reach US$ 228.11 million by 2030.
Related Reports
pharmaceuticalsLipodystrophy Market Size, Share, Industry, Trends, and Outlook (2023-2030)
Published: 2023 December 26
Starting from
$4350
clinical-diagnosticsHIV Diagnostics Testing Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 February 03
Starting from
$3750
pharmaceuticalsProphylactic HIV Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 25
Starting from
$4350